amlodipine and olmesartan medoxomil

Generic: amlodipine and olmesartan medoxomil

Labeler: amneal pharmaceuticals ny llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amlodipine and olmesartan medoxomil
Generic Name amlodipine and olmesartan medoxomil
Labeler amneal pharmaceuticals ny llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

amlodipine besylate 5 mg/1, olmesartan medoxomil 40 mg/1

Manufacturer
Amneal Pharmaceuticals NY LLC

Identifiers & Regulatory

Product NDC 69238-2676
Product ID 69238-2676_31d0d1f2-a0c7-4cd3-80d2-d9f231687adc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209010
Listing Expiration 2026-12-31
Marketing Start 2018-12-03

Pharmacologic Class

Classes
angiotensin 2 receptor antagonists [moa] angiotensin 2 receptor blocker [epc] calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 692382676
Hyphenated Format 69238-2676

Supplemental Identifiers

RxCUI
730861 730866 730869 730872
UPC
0369238267617 0369238267518 0369238267310 0369238267419
UNII
864V2Q084H 6M97XTV3HD

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amlodipine and olmesartan medoxomil (source: ndc)
Generic Name amlodipine and olmesartan medoxomil (source: ndc)
Application Number ANDA209010 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
  • 40 mg/1
source: ndc
Packaging
  • 1000 TABLET, FILM COATED in 1 BOTTLE (69238-2676-1)
source: ndc

Packages (1)

Ingredients (2)

amlodipine besylate (5 mg/1) olmesartan medoxomil (40 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "31d0d1f2-a0c7-4cd3-80d2-d9f231687adc", "openfda": {"upc": ["0369238267617", "0369238267518", "0369238267310", "0369238267419"], "unii": ["864V2Q084H", "6M97XTV3HD"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_set_id": ["02f9b562-6f7f-4783-bb0d-67c318073e1c"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (69238-2676-1)", "package_ndc": "69238-2676-1", "marketing_start_date": "20181203"}], "brand_name": "Amlodipine and Olmesartan Medoxomil", "product_id": "69238-2676_31d0d1f2-a0c7-4cd3-80d2-d9f231687adc", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "69238-2676", "generic_name": "Amlodipine and Olmesartan Medoxomil", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and Olmesartan Medoxomil", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "ANDA209010", "marketing_category": "ANDA", "marketing_start_date": "20181203", "listing_expiration_date": "20261231"}